최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기생물정신의학 = Korean journal of biological psychiatry, v.24 no.1, 2017년, pp.19 - 25
예신희 (이화여자대학교 의과대학 직업환경의학교실) , 김현주 (이화여자대학교 이대부속목동병원 작업환경의학과) , 정최경희 (이화여자대학교 의과대학 직업환경의학교실) , 김지은 (이화여자대학교 뇌융합과학연구원) , 박신원 (이화여자대학교 뇌융합과학연구원) , 이유민 (이화여자대학교 의과대학 직업환경의학교실) , 하은희 (이화여자대학교 의과대학 직업환경의학교실)
Previous studies have found that firefighters have a tenfold higher prevalence of Parkinson's disease (PD) compare to the general population. Firefighters are constantly exposed to various occupational hazards including toxic chemicals of fire residue and the toxic chemicals can effects development ...
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
일산화탄소의 위험성은? | 일산화탄소는 산소에 비해 헤모글로빈 친화력이 210배로 높아 산소를 대체하여 체내에서 일산화탄소-헤모글로빈을 형성하며 저산소증을 유발하고,34) 저산소증은 활성산소를 형성하게 하여 산화스트레스를 야기하고 이는 저산소 상태에 민감한 조직인 뇌나 심장에 손상을 일으킬 수 있다.35) | |
파킨슨병의 운동 증상은? | 9) 병리적인 특징으로 흑질세밀부(substantia nigra pars compacta), 나청반(locus coeruleus)에서의 신경 세포 소실과 교세포의 증식이 관찰되고, 그 외 변성되고 있는 신경세포 내에 유비퀴틴(ubiquitin) 양성 호산성 세포질 내 봉입체(eosinophilic cytoplasmic inclusion body)가 보이는 것으로 알려져 있다.10) 특징적인 운동 증상으로는 운동완만(bradykinesia), 떨림(tremor), 경축(rigidity), 자세의 불안정(postural instability), 보행 장애(gait disturbance)와 같은 증상이 있다.11) 이 외에도 파킨슨병은 우울감, 불면과 같은 증상이 자주 동반되고, 파킨슨병 치료제의 부작용으로서 환청이나 망상 같은 정신증과 충동조절문제 등이 많이 발생하기도 하여, 신경과 분야뿐 아니라, 정신건강의학 분야에서도 중요한 치료 및 연구 대상이다. | |
소방관은 업무가 건강에 끼치는 영향은? | 소방관은 업무를 수행하는 과정에서 일산화탄소, 시안화 물, 중금속, 아크롤레인, 염화수소, 일산화질소 등의 화재 연소 부산물을 흡입하게 되고, 이로 인해 호흡기 질환,1) 심혈관계 질환,2) 신경계 질환,3) 암4) 등 다양한 질병이 발생하거나 이러한 질병으로 인한 사망률이 증가할 수 있다.5) 하지만 소방관들의 화재 연소 부산물 노출과 관련된 신경계질환에 대한 연구는 드문 상태이다. |
Adetona O, Reinhardt TE, Domitrovich J, Broyles G, Adetona AM, Kleinman MT, et al. Review of the health effects of wildland fire smoke on wildland firefighters and the public. Inhal Toxicol 2016;28:95-139.
Rosenstock L, Olsen J. Firefighting and death from cardiovascular causes. N Engl J Med 2007;356:1261-1263.
Schulte PA, Burnett CA, Boeniger MF, Johnson J. Neurodegenerative diseases: occupational occurrence and potential risk factors, 1982 through 1991. Am J Public Health 1996;86:1281-1288.
LeMasters GK, Genaidy AM, Succop P, Deddens J, Sobeih T, Barriera-Viruet H, et al. Cancer risk among firefighters: a review and meta-analysis of 32 studies. J Occup Environ Med 2006;48:1189-1202.
Kim GS. Health hazards in firefighters. Korean Ind Health Assoc 2005;2:9-19.
Minerbo GM, Jankovic J. Prevalence of Parkinson's disease among firefighters. Neurology 1990;40(Suppl):348.
Duda JE, Giasson BI, Mabon ME, Miller DC, Golbe LI, Lee VM, et al. Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred. Acta Neuropathol 2002;104:7-11.
Spencer DD, Robbins RJ, Naftolin F, Marek KL, Vollmer T, Leranth C, et al. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med 1992;327:1541-1548.
Jeong HG. Nationwide survey on the prevalence of Parkinson's disease in Korea. Center for Disease Control & Prevention;2007.
Hornykiewicz O. Dopamine (3-hydroxytyramine) and brain function. Pharmacol Rew 1966;18:925-964.
Ko SB. Diagnosis and treatment of Parkinson's disease. J Korean Acad Fam Med 2003;24:1059-1068.
Schirinzi T, Martella G, D'Elia A, Di Lazzaro G, Imbriani P, Madeo G, et al. Outlining a Population "at Risk" of Parkinson's Disease: Evidence from a Case-Control Study. Parkinsons Dis 2016;2016:9646057.
Bolstad-Johnson DM, Burgess JL, Crutchfield CD, Storment S, Gerkin R, Wilson JR. Characterization of firefighter exposures during fire overhaul. AIHAJ 2000;61:636-641.
Edelman P, Osterloh J, Pirkle J, Caudill SP, Grainger J, Jones R, et al. Biomonitoring of chemical exposure among New York City firefighters responding to the World Trade Center fire and collapse. Environ Health Perspect 2003;111:1906-1911.
Caux C, O'Brien C, Viau C. Determination of firefighter exposure to polycyclic aromatic hydrocarbons and benzene during fire fighting using measurement of biological indicators. Appl Occup Environ Hyg 2002;17:379-386.
Barnard RJ, Weber JS. Carbon monoxide: a hazard to fire fighters. Arch Environ Health 1979;34:255-257.
Baxter CS, Hoffman JD, Knipp MJ, Reponen T, Haynes EN. Exposure of firefighters to particulates and polycyclic aromatic hydrocarbons. J Occup Environ Hyg 2014;11:D85-D91.
Brandt-Rauf PW, Fallon LF Jr, Tarantini T, Idema C, Andrews L. Health hazards of fire fighters: exposure assessment. Br J Ind Med 1988;45:606-612.
Kim JM, Lee HJ. Hazards exposed to firefighters in fire: physical, chemical, and biologic factors. J Korean Med Assoc 2008;51:1072-1077.
Laitinen J, Makela M, Mikkola J, Huttu I. Firefighters' multiple exposure assessments in practice. Toxicol Lett 2012;213:129-133.
Lai CY, Chou MC, Lin CL, Kao CH. I ncreased r isk of Parkinson disease in patients with carbon monoxide intoxication: a population based cohort study. Medicine (Baltimore) 2015;94:e869.
Seidler A, Hellenbrand W, Robra BP, Vieregge P, Nischan P, Joerg J, et al. Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany. Neurology 1996;46:1275-1284.
Pals P, Van Everbroeck B, Grubben B, Viaene MK, Dom R, van der Linden C, et al. Case-control study of environmental risk factors for Parkinson's disease in Belgium. Eur J Epidemiol 2003;18:1133-1142.
Dhillon AS, Tarbutton GL, Levin JL, Plotkin GM, Lowry LK, Nalbone JT, et al. Pesticide/environmental exposures and Parkinson's disease in East Texas. J Agromedicine 2008;13:37-48.
Willis AW, Evanoff BA, Lian M, Galarza A, Wegrzyn A, Schootman M, et al. Metal emissions and urban incident Parkinson disease: a community health study of medicare beneficiaries by using geographic information systems. Am J Epidemiol 2010;172:1357-1363.
Dick FD, De Palma G, Ahmadi A, Scott NW, Prescott GJ, Bennett J, et al. Environmental risk factors for Parkinson's disease and Parkinsonism: the Geoparkinson study. Occup Environ Med 2007;64:666-672.
Gorell JM, Peterson EL, Rybicki BA, Johnson CC. Multiple risk factors for Parkinson's disease. J Neurol Sci 2004;217:169-174.
Weisskopf MG, Weuve J, Nie H, Saint-Hilaire MH, Sudarsky L, Simon DK, et al. Association of cumulative lead exposure with Parkinson's disease. Environ Health Perspect 2010;118:1609-1613.
Coon S, Stark A, Peterson E, Gloi A, Kortsha G, Pounds J, et al. Whole-body lifetime occupational lead exposure and risk of Parkinson's disease. Environ Health Perspect 2006;114:1872-1876.
Rybicki BA, Johnson CC, Peterson EL, Kortsha GX, Gorell JM. A family history of Parkinson's disease and its effect on other PD risk factors. Neuroepidemiology 1999;18:270-278.
Kirrane EF, Bowman C, Davis JA, Hoppin JA, Blair A, Chen H, et al. Associations of ozone and PM2.5 concentrations with parkinson's disease among participants in the agricultural health study. J Occup Environ Med 2015;57:509-517.
Palacios N, Fitzgerald KC, Hart JE, Weisskopf MG, Schwarzschild MA, Ascherio A, et al. Particulate matter and risk of Parkinson disease in a large prospective study of women. Environ Health 2014;13:80.
Ganong WF. Review of medical physiology. London: Prentice-Hall International;1995.
Zhang J, Piantadosi CA. Mitochondrial oxidative stress after carbon monoxide hypoxia in the rat brain. J Clin Invest 1992;90:1193-1199.
Kanthasamy AG, Borowitz JL, Pavlakovic G, Isom GE. Dopaminergic neurotoxicity of cyanide: neurochemical, histological, and behavioral characterization. Toxicol Appl Pharmacol 1994;126:156-163.
Smith RP, Gosselin RE. Hydrogen sulfide poisoning. J Occup Med 1979;21:93-97.
Haider SS, Hasan M. Neurochemical changes by inhalation of environmental pollutants sulfur dioxide and hydrogen sulfide: degradation of total lipids, elevation of lipid peroxidation and enzyme activity in discrete regions of the guinea pig brain and spinal cord. Ind Health 1984;22:23-31.
Zeliger HI. Exposure to lipophilic chemicals as a cause of neurological impairments, neurodevelopmental disorders and neurodegenerative diseases. Interdiscip Toxicol 2013;6:103-110.
Voog L, Eriksson T. Toluene-induced decrease in rat plasma concentrations of tyrosine and tryptophan. Acta Pharmacol Toxicol (Copenh) 1984;54:151-153.
Juorio AV, Yu PH. Effects of benzene and other organic solvents on the decarboxylation of some brain aromatic-L-amino acids. Biochem Pharmacol 1985;34:1381-1387.
Patri M, Padmini A, Babu PP. Polycyclic aromatic hydrocarbons in air and their neurotoxic potency in association with oxidative stress: a brief perspective. Ann Neurosci 2009;16:22-30.
Hirsch EC, Faucheux BA. Iron metabolism and Parkinson's disease. Mov Disord 1998;13 Suppl 1:39-45.
Paik SR, Shin HJ, Lee JH, Chang CS, Kim J. Copper(II)-induced self-oligomerization of alpha-synuclein. Biochem J 1999;340(Pt 3):821-828.
Munch G, Gerlach M, Sian J, Wong A, Riederer P. Advanced glycation end products in neurodegeneration: more than early markers of oxidative stress? Ann Neurol 1998;44(3 Suppl 1):S85-S88.
Oberdorster G, Sharp Z, Atudorei V, Elder A, Gelein R, Kreyling W, et al. Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 2004;16:437-445.
Block ML, Calderon-Garciduenas L. Air pollution: mechanisms of neuroinflammation and CNS disease. Trends Neurosci 2009;32:506-516.
Veronesi B, Makwana O, Pooler M, Chen LC. Effects of subchronic exposures to concentrated ambient particles. VII. Degeneration of dopaminergic neurons in Apo E-/- mice. Inhal Toxicol 2005;17:235-241.
Levesque S, Surace MJ, McDonald J, Block ML. Air pollution & the brain: subchronic diesel exhaust exposure causes neuroinflammation and elevates early markers of neurodegenerative disease. J Neuroinflammation 2011;8:105.
Levesque S, Taetzsch T, Lull ME, Kodavanti U, Stadler K, Wagner A, et al. Diesel exhaust activates and primes microglia: air pollution, neuroinflammation, and regulation of dopaminergic neurotoxicity. Environ Health Perspect 2011;119:1149-1155.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.